Evidence map›Paper›PMID 41080721›Full record

ArticleMaterials today. Bio2025

Dual-metal-organic framework and gallic acid incorporated 3D-printed scaffolds: Revolutionizing refractory bone defect repair through immune-angiogenic-neurogenic synergy.

Yongbo Li, Yifei Guo, Yuanpei Cheng, Xiaodong Liu, Hengren Li, Chen Liu, Xipeng Chen, Heng Yang, Xingzhi Jing, Xiaoyang Liu and 4 more

Abstract read
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yongbo LiDepartment of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250000, Shandong, PR China.
Yifei GuoDepartment of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250000, Shandong, PR China.
Yuanpei ChengState Key Laboratory of Polymer Science and Technology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, PR China.
Xiaodong LiuDepartment of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250000, Shandong, PR China.
Hengren LiDepartment of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250000, Shandong, PR China.
Chen LiuDepartment of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250000, Shandong, PR China.
Xipeng ChenDepartment of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, 130000, PR China.
Heng YangDepartment of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250000, Shandong, PR China.
Xingzhi JingDepartment of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250000, Shandong, PR China.
Xiaoyang LiuDepartment of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250000, Shandong, PR China.
Han WuDepartment of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, 130000, PR China.
Min GuoState Key Laboratory of Polymer Science and Technology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, PR China.
Peibiao ZhangState Key Laboratory of Polymer Science and Technology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, PR China.
Xingang CuiDepartment of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250000, Shandong, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Steroid-associated osteonecrosis (SAON)-related bone defects are refractory and present significant therapeutic challenges due to dysregulated multiple cellular functions and disrupted multidimensional microenvironments. Despite progress in regulating immune responses and promoting vascularization for SAON-related bone defects, effective neural innervation strategies remain limited. Notably, immune response, angiogenesis, and neural innervation are interdependent processes that collectively regulate bone regeneration. Herein, we engineered a novel 3D-printed composite scaffold with highly interconnected porosity and multiple bioactivities by integrating magnesium-copper dual-metal-organic framework (MgCu-MOF74), gallic acid (GA) and polylactic acid (PLA). MgCu-MOF74 exhibits antioxidant capacity, controllable release of metal ions, and osteo-angiogenic properties. The composite scaffold demonstrated excellent mechanical properties and degradation characteristics well suited for bone regeneration. More importantly, the incorporation of GA and dual-ion synergy enabled the scaffold to achieve pronounced multicellular modulation by promoting macrophage polarization, inducing endothelial cell-mediated angiogenesis, stimulating Schwann cell morphological maturation, and enhancing the osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs), while markedly increasing intercellular crosstalk to optimize the local multidimensional microenvironment. In vivo studies further confirmed that the scaffold effectively facilitates the repair of SAON-related bone defects by harnessing the synergistic interactions among the immune, angiogenic, and neurogenic microenvironments. This work provides an innovative strategy for treating refractory SAON - related bone defects, highlighting the potential of the developed scaffold in modulating diverse cell types and remodeling complex microenvironments.

Indexed as

3D printing scaffoldGallic acidMetal-organic frameworksMulticellular modulationNeurogenesisRefractory bone defect

Identifiers

PMID41080721
PMCPMC12512983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.